Recruiting
Phase 2

CIT-013

Sponsor:

Citryll BV

Code:

NCT06993233

Conditions

Hidradenitis Suppurativa (HS)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CIT-013 high dose

CIT-013 medium dose

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-02. This information was provided to ClinicalTrials.gov by Citryll BV on 2026-01-29.